40:17
PILA PHARMA x #STOKK.io After-Work Q&A [October 28, 2024]
20:40
PILA PHARMA x #REDEYE #Cardiovascular & #Metabolic day [October 17, 2024]
21:31
PILA PHARMA x #REDEYE H1 Report & Q&A [August 29, 2024]
25:54
PILA PHARMA x #AKTIESPARARNA - H1 Report & Q&A [August 28, 2024]
28:39
PILA PHARMA x #Stokk.io - H1 Report & Q&A [August 27, 2024]
25:07
PILA PHARMA x #Aktiespararna [JUNE 12th, 2024]
04:25
PILA PHARMA x INTERNATIONAL SYMPOSIUM ON DIABETES & NUTRITION, JUNE 28TH 2024
19:21
PILA PHARMA x #Redeye Diabetes Day [May 23rd, 2024]
20:11
PILA PHARMA x Stokk.io - NEW #CEO Q&A [April 22nd, 2024]
20:23
PILA PHARMA x #Redeye Investor Forum [April 11th, 2024]
28:13
PILA PHARMA x Aktiespararna - Life Science dagen [April 17th 2024]
26:09
PILA PHARMA x #InvestorDagen, Odense, Denmark [April 16th, 2024] Dansk Aktionær Forening
44:24
PILA PHARMA x Stokk.io - Q4 2023 Year-End update & Q&A [February 28th 2024]
21:08
Discussion on the #Obesity market, #future #weightloss solutions and #investment thoughts
18:32
A conversation on how to treat possibly #Diabetes & #Obesity with #TRPV1-antagonists
15:11
PILA PHARMA x INV€$TIVAL - An alternative solution to new obesity and diabetes, November 13, 2023
00:39
PILA PHARMA - World #Diabetes day 2023
17:20
PILA PHARMA x LSX Nordic 11/10/2023 (#TRPV1 antagonist treatment for #obesity & #diabetes) New data!
11:41
Pila Pharma at ADA AMERICAN DIABETES ASSOCIATION CONVENTION – SAN DIEGO 2023
18:35
Pila Pharma Erythromelalgia
20:43
Pila Pharma: CEO Dorte X Gram presents at Redeye Diabetes Event – May, 2023
11:26
PILA PHARMA interview with potential new shareholder
10:25
PILA PHARMA interview with long-term investor
10:28
PILA PHARMA interview with pain-relief expert Hans Quiding
08:09
Pila Pharma interview with long-term shareholder
02:40
How one can subscribe in our ongoing Rights Issue
13:18
Pila Pharma REDEYE 26 04 22
03:00
Pila Pharma / TRPV1
X
About
Tags